Antileishmanial [EPC]

372 reported adverse events

Drugs of this class: MILTEFOSINE

These side effects are most commonly reported by patients taking drugs of the Antileishmanial [EPC] class:

# Side effect Count
0 OFF LABEL USE 116
1 DRUG INEFFECTIVE 105
2 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 57
3 NAUSEA 52
4 CONDITION AGGRAVATED 33
5 VOMITING 27
6 PRODUCT USE IN UNAPPROVED INDICATION 26
7 DISEASE RECURRENCE 24
8 VISCERAL LEISHMANIASIS 20
9 RENAL FAILURE 17
See all common reactions for Antileishmanial [EPC]

Drugs of the Antileishmanial [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY CORNEA 1 0.3333
1 AMOEBIC BRAIN ABSCESS 2 0.2500
2 BALAMUTHIA INFECTION 6 0.2069
3 ACANTHAMOEBA KERATITIS 7 0.1892
4 ENCEPHALITIS PROTOZOAL 3 0.1071
5 ACANTHAMOEBA INFECTION 14 0.0833
6 GOOD SYNDROME 1 0.0588
7 MUCOCUTANEOUS LEISHMANIASIS 6 0.0496
8 RICKETTSIOSIS 1 0.0476
9 KWASHIORKOR 1 0.0417
See all enriched reactions for Antileishmanial [EPC]